Antithrombotic drugs are important means to prevent and treat thrombotic diseases. With the wider use of antithrombotic drugs, the incidence of antithrombotic drug-related bleeding has increased year by year. Anticoagulant drugs, antiplatelet drugs and thrombolytic drugs can all cause subcutaneous hemorrhage, gastrointestinal hemorrhage and even intracranial hemorrhage, resulting in death or disability. Therefore, the Chinese Society of Thrombosis, Hemostasis and Critical Care organized multidisciplinary experts to jointly write this specification to help clinicians regulate the treatment of antithrombotic drug-related bleeding. This specification includes four parts: antithrombotic drug monitoring, bleeding evaluation, reversal treatment and restart of antithrombotic treatment.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |